Keloid Scars
6
2
3
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 65/100
16.7%
1 terminated out of 6 trials
50.0%
-36.5% vs benchmark
67%
4 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Microneedling vs. 5-Fluorouracil or Steroid Injections for Hypertrophic Scars and Keloids
Topical Cryotherapy and Keloid/Hypertrophic Scars
Evaluation of Clinical, Perceived and Instrumental Efficacy of a Scar Gel in Preventing Hypertrophic Scars
Comparison of Intralesional Triamcinolone Versus Verapamil for Keloid Treatment
The Effectiveness of Intralesional Botulinum Toxin A and Triamcinolone Acetonide Injections in Keloid Treatment
Verapamil vs Steroid to Prevent Keloid Recurrence